PCOS Pregnancy Risks: GDM, Preeclampsia, and What to Monitor

You are early in pregnancy after PCOS, you have just read another scary statistics page, and you want a clear answer rather than a doom list. PCOS does not end at the positive pregnancy test, but the picture is manageable. This post walks through the PCOS pregnancy risks that actually change your prenatal plan, what your obstetric team is going to do about it, and what you can do at home.

PCOS in pregnancy raises specific, measurable risks. The largest are gestational diabetes (GDM) at roughly twice the background rate and hypertensive disorders of pregnancy at roughly three to four times the background rate.^{2 3} Preterm birth is modestly more common, and large-for-gestational-age babies are more common when GDM is poorly controlled. Absolute risks are still moderate, not catastrophic. The job of the prenatal team is to find a developing problem early and treat it well, not to manage your pregnancy as a disaster waiting to happen. The 2023 International PCOS Guideline (Teede and colleagues) sets out specific surveillance recommendations for PCOS in pregnancy, and most modern OB units have moved toward those protocols.¹

What we actually know about PCOS pregnancy risks

Meta-analyses across multiple cohorts are consistent. The numbers run roughly a 2-fold relative risk of GDM, a 3 to 4-fold relative risk of preeclampsia and pregnancy-induced hypertension, and about a 1.5-fold relative risk of preterm birth.^{2 3} Large-for-gestational-age (LGA) babies are also more common when GDM is not well controlled. The Boomsma meta-analysis from 2006 was the foundational paper; the Bahri Khomami 2019 update with meta-regression adjusted for obesity confirmed that the elevated maternal pregnancy complications in PCOS are not purely driven by BMI.^{2 3}

Risk varies with PCOS phenotype. Insulin-resistant PCOS drives most of the GDM and LGA signal. Hyperandrogenic phenotypes contribute more of the hypertensive disorder signal. Lean PCOS still carries elevated metabolic risk, just at lower absolute rates than PCOS with obesity. The relevant clinical implication is that "PCOS but normal BMI" does not mean "no extra monitoring."

This is also a "team of variables" rather than a "PCOS verdict." Age, BMI, prior pregnancy history, prior GDM, family history of preeclampsia, conception via ART, and twin pregnancies all stack with PCOS. Your individualised risk is your team's job to estimate, ideally at the booking visit.

Gestational diabetes, the headline risk

Background GDM affects roughly 6 to 9 percent of pregnancies in general populations. With PCOS the pooled relative risk is approximately 2.0 to 2.9 across meta-analyses.^{2 3}

Screening timing: ACOG and the American Diabetes Association both recommend early screening (first trimester) in high-risk groups, which includes PCOS.^{5 6} The early test is usually fasting glucose, HbA1c, or an early 75g oral glucose tolerance test (OGTT). The universal 24 to 28 week 75g OGTT still applies even if the early screen was normal. NICE NG3 in the UK also recommends early screening in PCOS.

Diagnostic thresholds, 75g OGTT, IADPSG/WHO 2013 criteria: Fasting glucose 92 mg/dL (5.1 mmol/L) or higher, 1-hour 180 mg/dL (10.0 mmol/L) or higher, 2-hour 153 mg/dL (8.5 mmol/L) or higher. One abnormal value is enough to make the diagnosis.

Metformin before and during pregnancy: Many people with PCOS are on metformin pre-pregnancy or during ovulation induction. The MIG trial (Rowan and colleagues, 2008) shown that metformin is a safe and effective option for treating GDM, with neonatal outcomes comparable to insulin.⁷ The question of whether to continue metformin from before pregnancy through pregnancy is team-specific; some continue, some stop at the positive test. Ask your obstetrician their reasoning rather than assuming the protocol from a previous cycle still applies.

Treatment if diagnosed: First-line is medical nutrition therapy and home glucose monitoring (fasting and post-meal). If targets are not met, metformin or insulin is added. A GDM diagnosis is not a failure or a reflection on the pregnancy; it is a label that triggers monitoring that often produces good outcomes.

Hypertensive disorders of pregnancy

The cluster includes gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome. Across pooled data, PCOS roughly triples the relative risk of preeclampsia compared with non-PCOS pregnancies.^{2 3} The absolute risk in any individual depends on the rest of the picture (BMI, age, parity, family history).

Aspirin prophylaxis: Low-dose aspirin from 12 weeks reduces preeclampsia risk in moderate-to-high-risk pregnancies. The USPSTF, ACOG, and NICE all recommend it for people who meet defined risk criteria.^{4 8} PCOS sits on most "moderate-risk" lists. Combined with another risk factor (BMI 30 or above, first pregnancy, age 35 or older, family history of preeclampsia, multiple gestation, ART conception), most PCOS pregnancies meet criteria. Dose differs by country: 81 mg is standard in US practice, 150 mg in UK practice. Start from 12 weeks, continue until delivery.

Blood pressure monitoring: Home BP cuff at booking. Weekly or fortnightly visits late in the second and third trimesters. The threshold for evaluation is sustained 140/90 mmHg. ACOG Practice Bulletin 222 is the standard reference.⁴

Red flag symptoms to learn: Persistent severe headache, visual disturbance (flashing lights, blurred vision, a curtain across vision), right-upper-quadrant or epigastric pain, sudden facial or hand swelling, decreased fetal movement. Any one of these is a same-day call, regardless of what the most recent BP reading was.

Preterm birth and LGA, the delivery considerations

Meta-analyses show roughly a 1.5-fold relative risk of preterm birth in PCOS pregnancies. The signal is driven mostly by indicated preterm delivery (delivering early for preeclampsia or for poorly controlled GDM with growth concerns) rather than by spontaneous preterm labour.

Large-for-gestational-age babies result from fetal hyperinsulinaemia in poorly controlled GDM. This affects mode-of-delivery discussions, shoulder dystocia risk in vaginal birth, and neonatal hypoglycaemia after birth. The counter-narrative is important: in well-controlled GDM with normal growth scans, vaginal birth is appropriate and expected. A PCOS pregnancy with controlled glucose does not default to cesarean.

What your prenatal monitoring should look like

Booking visit: Full booking labs plus HbA1c or early OGTT, baseline blood pressure, BMI, full pregnancy history, current PCOS treatment.

11 to 14 weeks: Aneuploidy screening. Some units add uterine artery Doppler as part of first-trimester preeclampsia risk modelling (the Fetal Medicine Foundation combined screen).

16 weeks: Start low-dose aspirin if indicated. Most PCOS pregnancies meet criteria with one additional risk factor.

24 to 28 weeks: Universal 75g OGTT, even if early screening was normal.

28 weeks onward: Weekly or fortnightly BP checks. Growth scans typically at 28, 32, and 36 weeks if there is any GDM, hypertension, or growth concern.

Throughout: Low threshold to escalate any red flag symptom. After IVF, the threshold for triage is appropriately lower than for a spontaneous pregnancy.

The third trimester, what is normal and what is not

The third trimester begins at 28 weeks 0 days of gestation, counted from the first day of the last menstrual period. This is the period in which most PCOS-related complications declare themselves.

Normal late-pregnancy changes: More frequent Braxton-Hicks contractions, mild dependent oedema, fatigue, reflux, restless sleep, shortness of breath on stairs.

Not normal: Severe headache, scotoma or flashing lights, right-upper-quadrant pain, decreased fetal movement, sudden brisk swelling of hands and face, BP at 140/90 mmHg or above on repeat checks, glucose readings persistently above target. Any one of these is a same-day review.

The third trimester is also when fetal growth restriction (in hypertensive disease) or fetal macrosomia (in GDM) declares itself on scan. The growth-scan cadence matters and is the reason for the closer monitoring schedule.

What you can do this trimester

• Take a home BP cuff seriously. Check twice weekly from 20 weeks, even if your team has not asked. Keep a log.
• Continue light activity (walking, prenatal yoga) unless contraindicated. Physical activity reduces GDM and hypertensive risk.
• Eat to glucose. Protein-forward breakfast, low-glycaemic carbohydrates, regular meals. This is the most evidence-based "preconception" advice that carries into pregnancy.
• Mental health is obstetric care. Anxiety after infertility is heightened in PCOS pregnancies. Screen yourself with PHQ-9 or GAD-7 quietly, and tell your team if either climbs.
• Sleep where you can. Sleep deprivation worsens insulin resistance and BP.

What to ask before your next appointment

These are the questions worth bringing to a booking visit when PCOS pregnancy risks are on the agenda. Most clinicians welcome them.

• "Am I being screened for GDM in the first trimester, not just at 28 weeks?"
• "Do I meet criteria for low-dose aspirin from 12 to 16 weeks? What dose are you recommending?"
• "Will growth scans be added in the third trimester? At what gestations?"
• "If I was on metformin before pregnancy, am I continuing? What is your team's reasoning?"
• "What is your threshold for escalating BP concerns to the maternal-fetal medicine team?"
• "Given my conception story (IVF, IUI, or natural after long TTC), do I qualify for additional surveillance?"

What's next

• For postpartum cycle return, lactation, and rebound: PCOS postpartum, cycle return and recovery
• For the broader second and third trimester pillar: second trimester changes and third trimester symptoms
• If anxiety is the dominant feature: PAI anxiety in later pregnancy
• If something goes wrong: when things don't go to plan

Sources

1. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
2. Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12(6):673-683. https://doi.org/10.1093/humupd/dml036
3. Bahri Khomami M, Joham AE, Boyle JA, et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity: a systematic review, meta-analysis, and meta-regression. Obesity Reviews 2019;20(5):659-674. https://doi.org/10.1111/obr.12829
4. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstet Gynecol 2020;135(6):e237-e260. https://doi.org/10.1097/AOG.0000000000003891
5. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 230: Obesity in Pregnancy / Gestational Diabetes Mellitus. Obstet Gynecol 2021. https://www.acog.org/clinical/clinical-guidance/practice-bulletin
6. American Diabetes Association. Management of Diabetes in Pregnancy: Standards of Care in Diabetes: 2024. Diabetes Care 2024;47(Suppl 1):S282-S294. https://doi.org/10.2337/dc24-S015
7. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (MiG Trial Investigators). Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358(19):2003-2015. https://doi.org/10.1056/NEJMoa0707193
8. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NICE Guideline NG133, 2019. https://www.nice.org.uk/guidance/ng133